Clinical trial
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical…
NCT00054041 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00054041 |
|---|---|
| Title | Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia |
| Official title | Phase II Evaluation Of SGN-00101 (HSP-E7) Fusion Protein In Women With Cervical Intraepithelial Neoplasia 3, CIN 3 |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection |
| Intervention type | Biological, Other, Procedure |
| Interventions | HspE7, therapeutic conventional surgery, laboratory biomarker analysis |
| Enrollment | 84 |
| Start date | Jun 1, 2004 |
| Primary completion | Jan 1, 2007 |
| First posted | Feb 6, 2003 |
| Last update posted | Jan 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: